ArkBio Advances Global Influenza Research with New Antiviral Drug Trial in Australia ArkBio has begun dosing healthy volunteers in Australia for Phase I trial of its innovative antiviral drug, AK0406, targeting influenza infections.

ArkBio Advances Global Influenza Research with New Antiviral Drug Trial in Australia #Shanghai #Australia #ArkBio #Antiviral_Drug #AK0406

IRBM Announces a Major Breakthrough in Zika Virus Drug Discovery IRBM has achieved a significant scientific breakthrough by discovering a potent allosteric inhibitor targeting the Zika virus, promising new antiviral therapies.

IRBM Announces a Major Breakthrough in Zika Virus Drug Discovery #Italy #Rome #IRBM #Zika_Virus #Antiviral_Drug

IRBM Achieves Major Milestone in Developing Zika Virus Inhibitor IRBM has made significant progress in drug discovery, unveiling a powerful allosteric inhibitor targeting the Zika virus protease. This finding could change treatment options against Zika.

IRBM Achieves Major Milestone in Developing Zika Virus Inhibitor #USA #Rome #IRBM #Zika_Virus #Antiviral_Drug